In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in

In FDA obesity drug battle with compounders, Texas court allows Novo Nordisk to weigh in

Source: 
Fierce Pharma
snippet: 

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper knockoff versions of popular weight loss drugs, Novo Nordisk will not have to sit idly by.